Li Shiyao, Cortez-Jugo Christina, Ju Yi, Caruso Frank
School of Science, RMIT University, Melbourne, Victoria 3000, Australia.
Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.
ACS Nano. 2024 Dec 10;18(49):33257-33263. doi: 10.1021/acsnano.4c13214. Epub 2024 Nov 27.
It has been nearly two decades since the term "protein corona" was coined. This term has since evolved to "biomolecular corona" or "biocorona" to capture the diverse biomolecules that spontaneously form on the surface of nanoparticles upon exposure to biological fluids and drive nanoparticle interactions with biological systems. In this Perspective, we highlight the significant progress in this field, including studies on nonprotein corona components, lipid nanoparticles, and the role of the corona in endogenous organ targeting. We also discuss research opportunities in this field, particularly the need for improved characterization and standardization of analysis and how recent advances in artificial intelligence and ex vivo models can improve our understanding of the biomolecular corona in guiding nanomedicine design.
自“蛋白质冠层”一词被创造以来,已经过去了近二十年。此后,这个术语演变为“生物分子冠层”或“生物冠层”,以涵盖在纳米颗粒暴露于生物流体时自发形成于其表面的各种生物分子,并驱动纳米颗粒与生物系统的相互作用。在这篇观点文章中,我们强调了该领域的重大进展,包括对非蛋白质冠层成分、脂质纳米颗粒以及冠层在内源性器官靶向中的作用的研究。我们还讨论了该领域的研究机会,特别是对改进分析表征和标准化的需求,以及人工智能和离体模型的最新进展如何能增进我们对生物分子冠层在指导纳米医学设计方面的理解。